These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 533260

  • 1. Pharmacokinetics of intravenous piperacillin in patients undergoing chronic hemodialysis.
    Francke EL, Appel GB, Neu HC.
    Antimicrob Agents Chemother; 1979 Dec; 16(6):788-91. PubMed ID: 533260
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of piperacillin in patients with moderate renal failure and in patients undergoing hemodialysis.
    Giron JA, Meyers BR, Hirschman SZ, Srulevitch E.
    Antimicrob Agents Chemother; 1981 Feb; 19(2):279-83. PubMed ID: 6214987
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of azlocillin in subjects with normal and impaired renal function.
    Leroy A, Humbert G, Godin M, Fillastre JP.
    Antimicrob Agents Chemother; 1980 Mar; 17(3):344-9. PubMed ID: 7425600
    [Abstract] [Full Text] [Related]

  • 4. Piperacillin pharmacokinetics in subjects with chronic renal failure.
    Thompson MI, Russo ME, Matsen JM, Atkin-Thor E.
    Antimicrob Agents Chemother; 1981 Mar; 19(3):450-3. PubMed ID: 6454382
    [Abstract] [Full Text] [Related]

  • 5. Intravenous azlocillin kinetics in patients on long-term hemodialysis.
    Aletta JM, Francke EF, Neu HC.
    Clin Pharmacol Ther; 1980 Apr; 27(4):563-6. PubMed ID: 7357815
    [Abstract] [Full Text] [Related]

  • 6. Kinetics of intravenous mezlocillin in chronic hemodialysis patients.
    Francke E, Mehta S, Neu HC, Appel GB.
    Clin Pharmacol Ther; 1979 Aug; 26(2):228-31. PubMed ID: 455891
    [Abstract] [Full Text] [Related]

  • 7. [Pharmacokinetics of azlocillin in chronic renal failure and hemodialysis patients].
    Fillastre JP, Humbert G, Leroy A, Godin M.
    Presse Med; 1984 Mar 29; 13(13):797-801. PubMed ID: 6231597
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of ranitidine after intravenous administration in hemodialysis patients.
    Garg DC, Baltodano N, Perez GO, Oster JR, Jallad NS, Weidler DJ.
    Pharmacology; 1985 Mar 29; 31(4):189-93. PubMed ID: 4059323
    [Abstract] [Full Text] [Related]

  • 9. The effect of hemodialysis on piperacillin pharmacokinetics.
    Heim-Duthoy KL, Halstenson CE, Abraham PA, Matzke GR.
    Int J Clin Pharmacol Ther Toxicol; 1986 Dec 29; 24(12):680-4. PubMed ID: 3818147
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Moxalactam pharmacokinetics during hemodialysis.
    Aronoff GR, Sloan RS, Mong SA, Luft FC, Kleit SA.
    Antimicrob Agents Chemother; 1981 Apr 29; 19(4):575-7. PubMed ID: 6454386
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.